Stay connected to our news and events via the Celanese social channel experience and see where we are improving the world through our people, products and processes.


Contact Us

Healthcare and Life
Sciences Solutions


Drug-Eluting Stents And Catheters

Modification of stents and catheters to decrease risk of in-stent restenosis and post-insertion infections and inflammation has become a major area of innovation. Elution of anti-inflammatory drugs and others through surface coatings is one of the most common enhancements of implantable devices.

Ethylene-vinyl acetate copolymers (EVA) copolymers are commercially established, clinically proven, safe materials to create drug eluting coatings on implantable devices. EVA copolymers have excellent film forming, drug eluting and adhesive properties to allow creation of elastic, mechanically robust and durable surface modifications on various types of surfaces and devices. EVA copolymers are compatible to various solution based and melt based coating processes.

Let us help

Contact us for help with customization


Solutions_controlled-release_desktop-teaser Solutions_controlled-release_mobile-teaser

Controlled Release

Learn more
Solutions_formulation-support_desktop-teaser Solutions_formulation-support_mobile-teaser

Formulation Support

Learn more
Solutions_regulatory-support_desktop-teaser Solutions_regulatory-support_mobile-teaser

Regulatory Support for Long Acting Drug Delivery

Learn more
LADD_products_Vitaldose_desktop-teaser LADD_products_Vitaldose_mobile-teaser

VitalDose® EVA

Discover reliable performance for pharmaceutical drug delivery applications.

Learn more Papers

This website uses 'cookies' to give you the best, most relevant experience. Using this website means you are Ok with this. You can change which cookies are set at any time - and find out more about them - by following this link.

Information on the processing of your personal data within the USA by Google and Marketo:
By clicking "Accept All", or selecting "Marketing" and/or "Analytical" and then clicking "Accept Selected", you also consent in accordance with Art. 49(1)(a) GDPR that your data may be processed in the USA. The USA is considered by the European Court of Justice to be a country with no adequate level of data protection according to EU standards. In particular, there is a risk that your data may be processed by US authorities for surveillance and investigation purposes, possibly without the opportunity for legal remedies. If you select “Necessary” and then click on "Accept Selected”, the transfer described above will not take place. You will find more detailed information in our privacy policy.